Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy S Reau

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Hepatology Communications|March 7, 2020
Chronic Viral Hepatitis: Current Management and Future DirectionsAlbert Do, Nancy S Reau
Clinics in Liver Disease|February 5, 2008
Vanishing bile duct syndromeNancy S Reau, Donald M Jensen
Hepatic Medicine : Evidence and Research|May 1, 2015
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?Sujit V Janardhan, Nancy S Reau
Clinical Obstetrics and Gynecology|January 19, 2023
The Spectrum of Hepatic Critical Care During Pregnancy: A Clinical ReviewLucía Rivera Matos, Nancy S Reau
Liver International : Official Journal of the International Association for the Study of the Liver|June 17, 2016
Generic medications for hepatitis CDonald M Jensen, Phoebe Sebhatu, Nancy S Reau
The American Journal of Gastroenterology|February 3, 2016
ACG Clinical Guideline: Liver Disease and PregnancyTram T Tran, Joseph Ahn, Nancy S Reau
Hepatology Communications|June 5, 2024
Autoimmune hepatitis: Current and future therapiesNancy S Reau, Craig S Lammert, Ethan M Weinberg
Journal of Gastroenterology and Hepatology|December 9, 2015
The benefit of paracentesis on hospitalized adults with cirrhosis and ascitesJohn N Gaetano, Dejan Micic, Andrew Aronsohn, et al.
Hepatology Communications|May 10, 2024
Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrenceArun J Sanyal, Kris V Kowdley, Nancy S Reau, et al.
Digestive Diseases and Sciences|June 15, 2021
Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-AnalysisHelena B Thomaides-Brears, Naim Alkhouri, Daniela Allende, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Hepatology Communications|March 7, 2020
Chronic Viral Hepatitis: Current Management and Future DirectionsAlbert Do, Nancy S Reau
Clinics in Liver Disease|February 5, 2008
Vanishing bile duct syndromeNancy S Reau, Donald M Jensen
Hepatic Medicine : Evidence and Research|May 1, 2015
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?Sujit V Janardhan, Nancy S Reau
Clinical Obstetrics and Gynecology|January 19, 2023
The Spectrum of Hepatic Critical Care During Pregnancy: A Clinical ReviewLucía Rivera Matos, Nancy S Reau
Liver International : Official Journal of the International Association for the Study of the Liver|June 17, 2016
Generic medications for hepatitis CDonald M Jensen, Phoebe Sebhatu, Nancy S Reau
The American Journal of Gastroenterology|February 3, 2016
ACG Clinical Guideline: Liver Disease and PregnancyTram T Tran, Joseph Ahn, Nancy S Reau
Hepatology Communications|June 5, 2024
Autoimmune hepatitis: Current and future therapiesNancy S Reau, Craig S Lammert, Ethan M Weinberg
Journal of Gastroenterology and Hepatology|December 9, 2015
The benefit of paracentesis on hospitalized adults with cirrhosis and ascitesJohn N Gaetano, Dejan Micic, Andrew Aronsohn, et al.
Hepatology Communications|May 10, 2024
Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrenceArun J Sanyal, Kris V Kowdley, Nancy S Reau, et al.
Digestive Diseases and Sciences|June 15, 2021
Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-AnalysisHelena B Thomaides-Brears, Naim Alkhouri, Daniela Allende, et al.
Pageof 2